- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02659839
Mortality in Cancer Patients Admitted to the Intensive Care Unit in a Resource-limited Setting
Mortality in Cancer Patients Admitted to the Intensive Care Unit in a Resource-limited Setting: A Prospective Cohort Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The management of cancer patients in the intensive care unit (ICU) has changed dramatically during the last two decades. Initial experiences showed high rates of hospital mortality, reaching up to 75-85% in patients requiring life-sustaining treatments, particularly mechanical ventilation. An increasing number of clinical experiences has been reported pointing to a significant improvement in survival of these patients. However, it is not clear if this results are generalizable to settings with resource constraints. Therefore, the purpose of this study is to determine 30 day mortality in cancer patients admitted to the intensive care unit in a resource limited setting.
This study is a prospective cohort of cancer patients admitted to the ICU in which the investigators will evaluate the prognostic of cancer patients admitted for a ICU trial or treatment in ICU without limitations. This study will not consider any change in the treatment plan of the patients. The source of the data will be the clinical records of the patients during the admission and the records of the cancer unit. There will be no direct contact of the research team with the patients or their family.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Region Metropolitana
-
Santiago, Region Metropolitana, Chile, 8207257
- Hospital Dr. Sótero del Río
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- 18 years-old or older
- Histological diagnosis or high clinical suspicious of cancer (solid /hematological), with the exception of non-melanoma skin cancer.
- Functional classification state between 0-3, according to Eastern Cooperative Oncology Group.
Admission to intensive care unit, because of one or more of the following criteria:
- Invasive or non-invasive ventilatory support due to acute respiratory failure.
- Use of vasopressor drugs due to hypotension defined as noradrenaline requirement higher than 0.1 microgram/Kg/min.
- Renal replacement therapy due to acute renal failure.
Exclusion Criteria:
- Absence of cancer recurrences in more than 5 years after diagnosis
- Functional classification state of 4, according to Eastern Cooperative Oncology Group.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Cancer patients admitted to the ICU
Patients with cancer admitted to the ICU.
No intervention will be administered.
|
There will be no change in the standard ICU treatment.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Mortality at 30 days
Time Frame: 30 days since ICU admission
|
30 days since ICU admission
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Mortality at 180 days
Time Frame: 180 days since ICU admission
|
180 days since ICU admission
|
Collaborators and Investigators
Investigators
- Principal Investigator: Sebastián Mondaca, MD, Pontificia Universidad Catolica de Chile
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 101015
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterHyundai Hope On WheelsRecruitingCancer | Pediatric Cancer | Survivorship | Cancer MetastaticUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditionsUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary CancerUnited States
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Case Comprehensive Cancer CenterCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer and other conditionsUnited States
Clinical Trials on Cancer patients admitted to the ICU
-
Nantes University HospitalAssistance Publique - Hôpitaux de Paris; Assistance Publique Hopitaux De MarseilleActive, not recruitingStress Disorders, Post-Traumatic | Family MembersFrance, Guadeloupe
-
Dunjin ChenCompletedIntensive Care Units | Posterior Reversible Encephalopathy SyndromeChina
-
University Hospital, GhentUniversitaire Ziekenhuizen KU Leuven; Jessa Hospital; University Hospital, Antwerp and other collaboratorsCompletedCritical Illness | Acute Kidney Injury | COVID-19 PneumoniaBelgium
-
Hospital Sirio-LibanesNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisCompletedElderly Patients Visiting the Emergency DepartmentFrance
-
King's College LondonUnknownHeart Failure | Patient Readmission | RegistriesUnited Kingdom
-
Paul EdwardsCompletedDecubitis UlcerUnited States
-
University of MonastirCompleted
-
University Hospital, LilleCompleted
-
Groupe Hospitalier Paris Saint JosephCompletedIntensive Care UnitsFrance